Navigation Links
Two Chemical Compounds Restore Healthy Glucose Levels In Obese Mice

Chemical compounds called PBA and TUDCA were found to restore healthy glucose levels and normal insulin action in obese and diabetic mice, according to new research.// The study is published in the August 25 issue of Science and was conducted by researchers from the Harvard School of Public Health (HSPH).

Type 2 diabetes - 90 to 95 percent of all diabetes cases - affects an estimated 18 million people in the United States, and causes some 200,000 deaths a year. Obesity is closely associated with insulin resistance and is one of the leading risk factors for type 2 diabetes. The molecular mechanisms that link these two metabolic diseases remain under investigation, and current therapeutic options are limited.

G?khan S. Hotamisligil, chair of the HSPH Department of Genetics and Complex Diseases, is the senior author of the Science paper. In 2004, he led a team that identified a major molecular pathway that causes diabetes. A cornerstone of that discovery was a hypothesis that the key to the obesity-diabetes connection might be found in the endoplasmic reticulum, or ER - a system of folded membranes and tubules in the cytoplasm of cells where proteins and lipids are manufactured, processed, and shipped around the cell. When unusual demands - such as excess fat - are put on the ER's capacity, the organelle starts failing, and the cell enters an emergency mode, emitting stress signals. The condition is called ER stress. Cellular inflammation, insulin resistance and diabetes result. (

Hotamisligil's team also previously identified the JNK gene as a key component linking inflammation to metabolic signaling and as a gene that interferes with insulin sensitivity.
ER stress appears to trigger abnormal JNK activity, which is often seen in obesity and type 2 diabetes.

In the new Scien ce paper, Hotamisligil; lead author Umut ?–zcan, a postdoctoral fellow; and their co-authors first identified compounds that alleviate ER stress in cellular models and demonstrated how two of these chemicals - PBA (4-phenyl butyric acid) and TUDCA (taurine-conjugated derivative) - reduced ER stress, prevented JNK activation, and restored normal glucose homeostasis in type 2 diabetic mice.

The researchers used the ob/ob murine model, where mice are both severely obese and insulin resistant. Oral administration of PBA (1 g per kg of body weight) was given to seven- to eight-week-old male ob/ob mice and to leaner, wild-type mice for 20 days. PBA reduced blood glucose levels in the ob/ob mice to those of their wild-type counterparts within four days; the levels were maintained for up to three weeks and were not associated with changes in body weight. PBA treatment also improved glucose tolerance in ob/ob mice, reduced the indicators of ER stress, and prevented JNK activation and suppression of insulin action in peripheral tissues.

Administration of TUDCA in a different set of ob/ob and wild-type mice normalized blood glucose levels within one week of treatment of the obese mice. TUDCA helped improve insulin response by reducing ER stress and suppressing JNK gene activation.

TUDCA and PBA treatment also appeared to interfere with the storage of fat in the liver, significantly reducing the presence of fatty liver disease -- a condition closely related to obesity and insulin resistance. One form of this disease - nonalcoholic steatohepatitis - is associated with inflammation and the creation of fibrous tissue, which can lead to cirrhosis.

PBA has been approved by the U.S. Food and Drug Administration for clinical use in urea-cycle disorders in humans. TUDCA has been used as a liver-protecting agent in human cholestatic liver diseases.

'Already used safely in people for some disorders, these compounds and others li ke them may warrant clinical investigation into their effects on type 2 diabetes in humans,' said Hotamisligil. 'If these compounds work in humans as they do in experimental models, they could dramatically change the approaches to treat many components of metabolic syndrome.'

Source: Eurekaler

Related medicine news :

1. Chemical in Gila monsters saliva yields Alzheimer drug
2. Chemical found in plants may be the treatment for leukemia
3. Chemicals in clear plastics can cause learning difficulties
4. Quitting Smoking Made Easy By Track Of New Chemical
5. Brain Chemical Identified For Drug Dependent Behavior
6. Block Immune System Chemical For Treating Asthma
7. Chest Pain Can Be Identified By New Tracer Chemical 30 Hours After Pain Relief
8. Chemical Signaling Helps Regulate Sensory Map Formation In The Brain
9. New Chemical May Halt HIV Infection
10. High Levels Of Cancer Chemical Found In Soft Drinks
11. Sedatives Derived From Chemicals Can Make Elderly Nervous
Post Your Comments:

(Date:11/27/2015)... ... 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over ... More than 3.7 billion people under the age of 50 – or 67% of ... WHO's first global estimates of HSV-1 infection . , "The data shocks us highly!" ...
(Date:11/27/2015)... DE (PRWEB) , ... November 27, 2015 , ... ... member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s ... an independent group of Microsoft Dynamics SL software users, partners, industry experts and ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... failing. Secura Consultants has prided itself for not only fulfilling the needs of ... protection solutions at an affordable price and providing top-tier customer service. However, there's ...
(Date:11/27/2015)... ... ... CBD College is proud to announce that on November 20th, ... its Diagnostic Medical Sonography program. CBD College is honored to join this very short ... universities in the state of California make the cut. CBD College is officially the ...
(Date:11/27/2015)... ... ... Dr. Thomas Dunlap and Dr. Patrick Coleman , cardiologist ... Medicine at St., Joseph Health System’s Santa Rosa Memorial Hospital , co-hosted the ... ways and require time-critical intervention to avoid large area heart damage and progressive infections ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... Nov. 25, 2015  ARKRAY USA ... to provide evidence demonstrating the accuracy of its blood ... on Insulin Resistance, Diabetes and Cardiovascular Disease in ... the Company,s GLUCOCARD ® 01 meter and the ... requirements. The ability to accurately measure glucose levels in ...
Breaking Medicine Technology: